Christopher Melén

Publikationer
CV
Populärvetenskap och samverkan

Artiklar

Article: CANNABIS AND CANNABINOID RESEARCH. 2023

Δ9-THC and CBD in Plasma, Oral Fluid, Exhaled Breath, and Urine from 23 Patients Administered Sativex.

Melén CM; Merrien M; Wasik AM; Sander B; Wahlin BE; Panagiotis G; Beck O
Article: CANCERS. 2023;15(5):1585

2-Arachidonoylglycerol Modulates CXCL12-Mediated Chemotaxis in Mantle Cell Lymphoma and Chronic Lymphocytic Leukemia.

Merrien M; Wasik AM; Melén CM; Morsy MHA; Sonnevi K; Junlén H-R; Christensson B; Wahlin BE; Sander B
Article: LEUKEMIA & LYMPHOMA. 2022;63(6):1387-1397

Clinical effects of a single dose of cannabinoids to patients with chronic lymphocytic leukemia.

Melén CM; Merrien M; Wasik AM; Panagiotidis G; Beck O; Sonnevi K; Junlén H-R; Christensson B; Sander B; Wahlin BE
Article: BRITISH JOURNAL OF HAEMATOLOGY. 2021;192(1):75-81

Survival of very elderly patients with diffuse large B-cell lymphoma according to treatment intensity in the immunochemotherapy era: a Swedish Lymphoma Register study.

Sonnevi K; Wästerlid T; Melén CM; Harrysson S; Smedby KE; Wahlin BE
Article: FRONTIERS IN IMMUNOLOGY. 2019;10:2085

Systemic and Intra-Nodal Activation of NK Cells After Rituximab Monotherapy for Follicular Lymphoma.

Enqvist M; Jacobs B; Junlén HR; Schaffer M; Melén CM; Friberg D; Wahlin BE; Malmberg K-J
Article: EXPERIMENTAL HEMATOLOGY & ONCOLOGY. 2019;8:7

The Karolinska experience of autologous stem-cell transplantation for lymphoma: a population-based study of all 433 patients 1994-2016.

Carlsten M; Jädersten M; Hellström A; Littmann K; Melén CM; Junlén HR; Sonnevi K; Ljungman P; Björkstrand B; Wahlin BE
Article: BRITISH JOURNAL OF HAEMATOLOGY. 2016;175(4):614-622

Chemotherapeutic intensity and survival differences in young patients with diffuse large B-cell lymphoma: a Swedish Lymphoma Registry study.

Melén CM; Enblad G; Sonnevi K; Junlén HR; Smedby KE; Jerkeman M; Wahlin BE
Article: BRITISH JOURNAL OF HAEMATOLOGY. 2016;175(1):102-114

The tumour microenvironment influences survival and time to transformation in follicular lymphoma in the rituximab era.

Blaker YN; Spetalen S; Brodtkorb M; Lingjaerde OC; Beiske K; Østenstad B; Sander B; Wahlin BE; Melen CM; Myklebust JH; Holte H; Delabie J; Smeland EB

Artiklar

Anställningar

Examina och utbildning

Nyheter från KI

Kalenderhändelser från KI